Low density lipoprotein and liposome mediated uptake and cytotoxic effect of N4-octadecyl-1-β-D-arabinofuranosylcytosine in Daudi lymphoma cells

British Journal of Cancer

Volumn 80, Issue 10, 1999, Pages 1542-1549

  Koller Lucae, S K M ^a   Schott, H ^b   Schwendener, R A ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Ara C; Daudi cells; Lipophilic derivative; Liposomes; Low density lipoproteins; Lymphocytes

Indexed keywords

CYTARABINE DERIVATIVE; LIPOSOME; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR;

ARTICLE; CELL MEMBRANE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOTOXICITY; DAUDI CELL; DISSOCIATION CONSTANT; HUMAN; HUMAN CELL; LYMPHOCYTE; LYMPHOMA CELL; PRIORITY JOURNAL; PROTEIN TRANSPORT;

ANTINEOPLASTIC AGENTS; BURKITT LYMPHOMA; CELL SURVIVAL; CYTARABINE; DRUG CARRIERS; ENDOCYTOSIS; HEAT; HUMANS; LIPOPROTEINS, LDL; LIPOSOMES; PROTEIN BINDING; RECEPTORS, LDL; TUMOR CELLS, CULTURED;

EID: 0033064478     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690558     Document Type: Article

References (28)

1. Abe I, Saito S, Hori K, Suzuki M and Sato H (1982) Role of dephosphorylation in accumulation of 1-β-D arabinofuranosylcytosine-5′-triphosphate in human lymphoblastic cell lines with reference to their drug sensitivity. Cancer Res 42: 2846-2851
2. Allison BA, Pritchard PH and Levy JG (1994) Evidence for low-density lipoprotein receptor-mediated uptake of benzoporphyrin derivative. Br J Cancer 69: 833-839
3. Firestone RA (1994) Low-density lipoprotein as a vehicle for targeting antitumor compounds to cancer cells. Bioconjug Chem 5: 105-113
4. Goldstein JL, Basu SK and Brown MS (1983) Receptor-mediated endocytosis of low-density lipoprotein in cultured cells. Methods Enzymol 98: 241-260
5. Goldstein JL and Brown MS (1977) The low-density lipoprotein pathway and its relation to atherosclerosis. Annu Rev Biochem 46: 897-930
6. 4-hexadecyl-1-β-D-arabinofuranosylcytosine, a lipophilic derivative of 1-β-D-arabinofuranosylcytosine. Br J Cancer 71: 957-962
7. 4-hexadecyl-1-β-D arabinofuranosylcytosine in the human leukemic cell lines K-562 and U-937. Cancer Chemother Pharmacol 36: 483-492
8. 4-hexadecyl-1-β-D-arabinofuranosylcytosine. Br J Cancer 72: 1067-1073
9. Jasanada F, Urizzi P, Souchard JP, Le Gaillard F, Favre G and Nepveu F (1996) Indium-111 labeling of low density lipoproteins with the DTPA-bis(stearylamide): evaluation as a potential radiopharmaceutical for tumor localization. Bioconjug Chem 7: 72-81
10. Juliano RL (1988) Factors affecting the clearance kinetics and tissue distribution of liposomes, microsperes and emulsions. Adv Drug Deliv Rev 2: 31-45
11. 4-octadecyl-1-β-D-arabinofuranosylcytosine, a new anticancer drug. J Pharmacol Exp Ther 282: 1572-1580
12. 4-octadecyl-1-β-D-arabinofuranosylcytosine (NOAC). Drug Metabol Dispos 27: 342-350
13. MacCoss M, Edwards JJ, Lagocki P and Rahman YE (1983) Phospholipid-nucleoside conjugates. The interaction of selected 1-β-D-arabinofuranosylcytosine-5′-diphosphate-L-1,2-diacylglycerols with serum lipoproteins. Biochem Biophys Res Common 116: 368-374
14. Morrison IE, Anderson CM, Georgiou GN, Stevenson GV and Cherry RJ (1994) Analysis of receptor clustering on cell surfaces by imaging fluorescent particles. Biophys J 67: 1280-1290
15. Rensen PCN, Schiffelers RM, Versluis AJ, Bijsterhosch MK, Van-Kuijk MM and van Berkel T (1997) Human recombinant apolipoprotein E-enriched liposomes can mimic low-density lipoproteins as carriers for the site-specific delivery of antitumor agenls. Mol Pharmacol 52: 445-455
16. Rinninger F, Brundert M, Jackle S, Kaiser T and Greten H (1995) Selective uptake of low-density lipoprotein associated cholesteryl esters by human fibroblasts, human HepG2 hepatoma cells and J774 macrophages in culture. Biochim Biophys Acta 1255: 141-153
17. Rubas W, Supersaxo A, Weder HG, Hartmann HR, Hengartner H, Schott H and Schwendener R (1986) Treatment of murine L1210 lymphoid leukemia and melanoma B16 with lipophilic cytosine arabinoside prodrugs incorporated into unilamellar liposomes. Int J Cancer 37: 146-154
18. Schott H, Häussler MP and Schwendener RA (1994) Synthese von 4-Alkyleytosinnucleosiden und deren cylostatische Wirkung im L1210 Leukämiemodell der Maus. Liebigs Ann Chem 465-470
19. 4-octadecyl-ara-C, NOAC. Drugs of the Future 20: 11-15
20. Stephan ZF and Yurachek EC (1993) Rapid fluorometric assay of LDL receptor activity by DiI-labeled LDL. J Lipid Res 34: 325-330
21. Swanson J, Bushnell A and Silverstein SC (1987) Tubular lysosome morphology and distribution within macrophages depend on the integrity of cytoplasmic microtubules. Proc Natl Acad Sci USA 84: 1921-1925
22. van Berkel TJ, van Dijk MCM, Bijsterbosh MK and Rensen PCN (1996) Drug targeting by neo-lipoproteins. J Controlled Release 41: 85-90
23. Viallard V, Lacombe C, Trocheris V, Tabacik C and Aliau S (1990) Metabolism of low-density lipoprotein in differentiated and undifferentiated HT29 colon cancer cells. Int J Cancer 46: 320-325
24. Vitols S, Soderberg Reid K, Masquelier M, Sjostrom B and Peterson C (1990) Low density lipoprotein for delivery of a water-insoluble alkylating agent to malignant cells. In vitro and in vivo studies of a drug-lipoprotein complex. Br J Cancer 62: 724-729
25. Vogler WR, Olson AC, Okamoto S, Shoji RL, Kuo JF, Berdel WE, Eihl H, Hajdu J and Nomura M (1991) Comparison of selective cytotoxicity of alkyl lysophospholipids. Lipids 26: 1418-1423
26. Wasan KM, Ramaswamy M, Cassidy SM, Kazemi M, Strobel FW and Thies RU (1997) Physical characteristics and lipoprotein distribution of liposomal nystatin in human plasma. Antimicrob Agents Chemother 41: 1871-1875
27. Yen CF, Kalunta CI, Chen FS, Kaptein JS, Lin CK and Lad PM (1994) Flow cytometric evaluation of LDL receptors using DiI-LDL uptake and its application to B and T lymphocytic cell lines. Immunol Methods 177: 55-67
28. Yen CF, Kalunta CI, Chen FS, Kaptein JS, Lin CK and Lad PM (1995) Regulation of low-density lipoprotein receptors and assessment of their functional role in Burkitt's lymphoma cells. Biochem Biophys Acta 1257: 47-57